Company Overview of Metabolic Solutions Development Company, LLC
Metabolic Solutions Development Company, LLC, a drug discovery and development company, investigates novel molecular targets and develops new therapeutics to treat metabolic diseases of aging. It provides MSDC-0160 and MSDC-0602, a therapeutic agents that treats patients diagnosed with type 2 diabetes, polycystic kidney disease, and neurodegenerative diseases that include Alzheimer’s and Parkinson’s diseases; and MSDC-new chemical entities that are non-thiazolidinediones oral mitochondrial membrane modulator insulin sensitizers for the treatment of type 2 diabetes. The company was founded in 2006 and is based in Kalamazoo, Michigan.
161 East Michigan Avenue
Kalamazoo, MI 49007
Founded in 2006
Key Executives for Metabolic Solutions Development Company, LLC
Metabolic Solutions Development Company, LLC Key Developments
Similar Private Companies By Industry
|NanoFex LLC||United States|
|Glycosan BioSystems, Inc.||United States|
|Elan Pharmaceutical Investments Ltd.||United States|
|Viking Therapeutics, Inc.||United States|
|Matinas Biopharma, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Metabolic Solutions Development Company, LLC, please visit www.msdrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.